UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1

Biochemical journal, 2015-03, Vol.466 (3), p.511-524

2015

Volltextzugriff (PDF)

STAT1-dependent signal integration between IFNγ and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosis

PloS one, 2014-12, Vol.9 (12), p.e113318-e113318

2014

Volltextzugriff (PDF)

Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet

Cardiovascular diabetology, 2014-02, Vol.13 (1), p.31-31, Article 31

2014

Volltextzugriff (PDF)

601 Development of improved small molecule STING agonists suitable for systemic administration

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A636-A636

2020

Volltextzugriff (PDF)

STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential

International reviews of immunology, 2016-09, Vol.35 (5), p.434-454

2016

Volltextzugriff (PDF)

Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors

Bioorganic & medicinal chemistry letters, 2020-12, Vol.30 (23), p.127560-127560, Article 127560

2020

Volltextzugriff (PDF)

Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension

Cardiovascular research, 2014-03, Vol.101 (3), p.464-472

2014

Volltextzugriff (PDF)

STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury

American journal of physiology. Renal physiology, 2019-02, Vol.316 (2), p.F277-F291

2019

Volltextzugriff (PDF)

Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?

Journal of Alzheimer's disease, 2016-01, Vol.50 (3), p.791

2016

Volltextzugriff (PDF)

Abstract 547: Toll-Like Receptor 4 Signaling induces Systolic Blood Pressure Increase with Age

Hypertension (Dallas, Tex. 1979), 2014-09, Vol.64 (suppl_1)

2014

Volltextzugriff (PDF)

Abstract 456: Role of Signal Transducer and Activator of Transcription protein (STAT)-1 in the Angiotensin II-induced Cardiovascular Damage

Hypertension (Dallas, Tex. 1979), 2014-09, Vol.64 (suppl_1)

2014

Volltextzugriff (PDF)

Abstract MP09: Vascular Rho-kinase Activation by Inflammatory Signaling Mediates Blood Pressure Increase in Overweight

Hypertension (Dallas, Tex. 1979), 2014-09, Vol.64 (suppl_1)

2014

Volltextzugriff (PDF)

Abstract 1281: Development and characterization of small molecule HPK1 inhibitors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1281-1281

2021

Volltextzugriff (PDF)

Abstract 2639: Development of small molecule selective inhibitors of GCN2 as an immunotherapy aimed at preventing immune escape of tumor cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2639-2639

2017

Volltextzugriff (PDF)

Abstract 4532A: Development of selective small molecule STING agonists suitable for systemic administration

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4532-4532A

2020

Volltextzugriff (PDF)

STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion

American Journal of Physiology: Cell Physiology, 2011-06, Vol.300 (6), p.C1337-C1344

2011

Volltextzugriff (PDF)

Variability of cognitive performance during hemodialysis: standardization of cognitive assessment

Dementia and geriatric cognitive disorders, 2014-01, Vol.38 (1-2), p.31

2014

Volltextzugriff (PDF)

Abstract 4983: Discovery and characterization of next-generation small molecule direct STING agonists

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4983-4983

2019

Volltextzugriff (PDF)

STAT1-Dependent Signal Integration between IFN[gamma] and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis

PloS one, 2014-12, Vol.9 (12)

2014

Volltextzugriff (PDF)

25

Cytokine (Philadelphia, Pa.), 2013-09, Vol.63 (3), p.248-249

2013

Volltextzugriff (PDF)

Development of small molecule inhibitors of IL-1β processing

New biotechnology, 2016-07, Vol.33, p.S76-S77

2016

Volltextzugriff (PDF)

Immunosuppression with 4SC-101, a novel inhibitor of dihydroorotate dehydrogenase, in a rat model of renal transplantation

Transplantation, 2012-06, Vol.93 (11), p.1101

2012

Volltextzugriff (PDF)

25: STAT2 and IRF9-dependent IFN-I signaling restores ISRE-mediated transcription and anti-viral activity independent of STAT1

Cytokine (Philadelphia, Pa.), 2013-09, Vol.63 (3), p.248-249

2013

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(16)
Humans
(12)
Animals
(9)
Atherosclerosis
(6)
Male
(6)
Biological And Medical Sciences
(5)
Gene Expression
(4)
Mice
(4)
Phosphorylation
(4)
Proteins
(4)
Rodents
(4)
Signal Transduction
(4)
Cytokines
(3)
Female
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Immunology
(3)
Inflammation
(3)
Interferon
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1

STAT1-dependent signal integration between IFNγ and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosis

Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet

601 Development of improved small molecule STING agonists suitable for systemic administration

STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential

Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors

Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension

STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury

Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?

Abstract 547: Toll-Like Receptor 4 Signaling induces Systolic Blood Pressure Increase with Age

Abstract 456: Role of Signal Transducer and Activator of Transcription protein (STAT)-1 in the Angiotensin II-induced Cardiovascular Damage

Abstract MP09: Vascular Rho-kinase Activation by Inflammatory Signaling Mediates Blood Pressure Increase in Overweight

Abstract 1280: New generation of STING agonists: Development and characterization of a novel series of systemic immunomodulators with improved potency

Abstract 1281: Development and characterization of small molecule HPK1 inhibitors

Abstract 2639: Development of small molecule selective inhibitors of GCN2 as an immunotherapy aimed at preventing immune escape of tumor cells

Abstract 4532A: Development of selective small molecule STING agonists suitable for systemic administration

Abstract 1947: Development and characterization of small molecule HPK1 inhibitors

STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion

Variability of cognitive performance during hemodialysis: standardization of cognitive assessment

Abstract 4983: Discovery and characterization of next-generation small molecule direct STING agonists

STAT1-Dependent Signal Integration between IFN[gamma] and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis

25

Development of small molecule inhibitors of IL-1β processing

Immunosuppression with 4SC-101, a novel inhibitor of dihydroorotate dehydrogenase, in a rat model of renal transplantation

25: STAT2 and IRF9-dependent IFN-I signaling restores ISRE-mediated transcription and anti-viral activity independent of STAT1

Suchergebnisse filtern